Protalix Biotherapeutics Inc banner
P

Protalix Biotherapeutics Inc
AMEX:PLX

Watchlist Manager
Protalix Biotherapeutics Inc
AMEX:PLX
Watchlist
Price: 2.9 USD 0.69%
Market Cap: $233.2m

Wall Street
Price Targets

PLX Price Targets Summary
Protalix Biotherapeutics Inc

Wall Street analysts forecast PLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.

Lowest
Price Target
10.1 USD
248% Upside
Average
Price Target
11.22 USD
287% Upside
Highest
Price Target
12.6 USD
334% Upside
Protalix Biotherapeutics Inc Competitors:
Price Targets
STG
Strip Tinning Holdings PLC
143% Upside
MGIC
Magic Software Enterprises Ltd
6% Upside

Revenue
Forecast

25% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
25% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 18%.

Net Income
Forecast

N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss
N/A
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-84%
Average Miss

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 30%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PLX's stock price target?
Price Target
11.22 USD

According to Wall Street analysts, the average 1-year price target for PLX is 11.22 USD with a low forecast of 10.1 USD and a high forecast of 12.6 USD.

What is Protalix Biotherapeutics Inc's Revenue forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Protalix Biotherapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 11%.

What is Protalix Biotherapeutics Inc's Operating Income forecast?
Projected CAGR
18%

The compound annual growth rate of Protalix Biotherapeutics Inc's operating income for the next 3 years is 18%.

What is Protalix Biotherapeutics Inc's Net Income forecast?
Projected CAGR
30%

The compound annual growth rate of Protalix Biotherapeutics Inc's net income for the next 3 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett